StockData
Trinity Biotech PLC logo

Trinity Biotech PLC (TRIB) stock

TRIBNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 30, 2026Score 1/30
$5.83−0.18 (-3.08%)

Close on Nov 18, 2026Market cap $108.99MP/E –Yield –

Trinity Biotech revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2025 it was $43.79M, down 28.9% from the year before. Over ten years it grew -7.9% a year on average. The highest annual figure on record is $101.98M in fiscal 2020.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$43.79M-28.9%
FY2024Dec 31, 2024$61.56M+8.3%
FY2023Dec 31, 2023$56.83M-9.1%
FY2022Dec 31, 2022$62.52M-23.0%
FY2021Dec 31, 2021$81.15M-20.4%
FY2020Dec 31, 2020$101.98M+12.8%
FY2019Dec 31, 2019$90.44M-6.8%
FY2018Dec 31, 2018$97.04M-2.1%
FY2017Dec 31, 2017$99.14M-0.5%
FY2016Dec 31, 2016$99.61M-0.6%
FY2015Dec 31, 2015$100.20M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2018Jun 30, 2018$25.00M–
Q2 FY2017Jun 30, 2017$25.45M–

More Trinity Biotech figures

See a number that looks wrong?